Universal Health Services Inc. (NYSE: UHS) stock fell -6.14% on Tuesday to $126.93 against a previous-day closing price of $135.24. With 1.12 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.7 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $134.82 whereas the lowest price it dropped to was $126.78. The 52-week range on UHS shows that it touched its highest point at $154.65 and its lowest point at $82.50 during that stretch. It currently has a 1-year price target of $151.69. With its current market cap of 8.99 billion, UHS has annualized dividend of $0.80 while the current yield stands at 0.63%. Beta for the stock currently stands at 1.27.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UHS was down-trending over the past week, with a drop of -5.57%, but this was down by -9.79% over a month. Three-month performance dropped to -13.89% while six-month performance fell -1.35%. The stock gained 4.96% in the past year, while it has lost -9.91% so far this year. A look at the trailing 12-month EPS for UHS yields 9.41 with Next year EPS estimates of 11.33. For the next quarter, that number is 2.42. This implies an EPS growth rate of -22.70% for this year and 11.37% for next year. EPS is expected to grow by 4.15% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 4.00%.
Float and Shares Shorts:
At present, 70.53 million UHS shares are outstanding with a float of 61.83 million shares on hand for trading. On Apr 27, 2023, short shares totaled 1.64 million, which was 2.35% higher than short shares on Mar 30, 2023. In addition to Mr. Alan B. Miller as the firm’s Founder & Exec. Chairman, Mr. Marc D. Miller serves as its CEO, Pres & Director.
Through their ownership of 102.54% of UHS’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 60.11% of UHS, in contrast to 5.11% held by mutual funds. Shares owned by individuals account for 37.22%. As the largest shareholder in UHS with 11.07% of the stake, The Vanguard Group, Inc. holds 7,017,568 shares worth 7,017,568. A second-largest stockholder of UHS, Fidelity Management & Research Co, holds 5,131,971 shares, controlling over 8.09% of the firm’s shares. First Eagle Investment Management is the third largest shareholder in UHS, holding 4,724,578 shares or 7.45% stake. With a 5.50% stake in UHS, the Fidelity Low Priced Stock Fund is the largest stakeholder. A total of 3,486,969 shares are owned by the mutual fund manager. The First Eagle Global Fund, which owns about 5.31% of UHS stock, is the second-largest Mutual Fund holder. It holds 3,368,166 shares valued at 506.4 million. Vanguard Total Stock Market ETF holds 2.98% of the stake in UHS, owning 1,886,456 shares worth 283.63 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, UHS reported revenue of $3.32B and operating income of $233.43M. The EBITDA in the recently reported quarter was $379.26M and diluted EPS was $2.20.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UHS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With UHS analysts setting a high price target of $165.00 and a low target of $139.00, the average target price over the next 12 months is $151.75. Based on these targets, UHS could surge 29.99% to reach the target high and rise by 9.51% to reach the target low. Reaching the average price target will result in a growth of 19.55% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded UHS stock several times over the past three months with 6 Buys and 8 Sells. In these transactions, 582,500 shares were bought while 547,791 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has risen to 10 over the past year. The total number of shares bought during that period was 786,405 while 741,967 shares were sold.